Economic support to patients in HIV and TB grants in Rounds 7 and 10 from the Global Fund to Fight AIDS, Tuberculosis and Malaria

29Citations
Citations of this article
168Readers
Mendeley users who have this article in their library.

Abstract

People with TB and/or HIV frequently experience severe economic barriers to health care, including out-of-pocket expenses related to diagnosis and treatment, as well as indirect costs due to loss of income. These barriers can both aggravate economic hardship and prevent or delay diagnosis, treatment and successful outcome, leading to increased transmission, morbidity and mortality. WHO, UNAIDS and the ILO argue that economic support of various kinds is essential to enable vulnerable people to protect themselves from infection, avoid delayed diagnosis and treatment, overcome barriers to adherence, and avert destitution. This paper analyses successful country proposals to the Global Fund to Fight AIDS, Tuberculosis and Malaria that include economic support in Rounds 7 and 10; 36 and 20 HIV and TB grants in Round 7 and 32 and 26, respectively, in Round 10. Of these, up to 84 percent included direct or indirect economic support for beneficiaries, although the amount constituted a very small proportion of the total grant. In TB grants, the objectives of economic support were generally clearly stated, and focused on mechanisms to improve treatment uptake and adherence, and the case was most clearly made for MDR-TB patients. In HIV grants, the objectives were much broader in scope, including mitigation of adverse economic and social effects of HIV and its treatment on both patients and families. The analysis shows that economic support is on the radar for countries developing Global Fund proposals, and a wide range of economic support activities are in place. In order to move forward in this area, the wealth of country experience that exists needs to be collated, assessed and disseminated. In addition to trials, operational research and programme evaluations, more precise guidance to countries is needed to inform evidence-based decision about activities that are cost-effective, affordable and feasible. © 2014 Richter et al.

References Powered by Scopus

Social determinants of health inequalities

3492Citations
N/AReaders
Get full text

Poverty and access to health care in developing countries

921Citations
N/AReaders
Get full text

Drivers of tuberculosis epidemics: The role of risk factors and social determinants

750Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Building a tuberculosis-free world: The Lancet Commission on tuberculosis

262Citations
N/AReaders
Get full text

Beyond UHC: Monitoring Health and Social Protection Coverage in the Context of Tuberculosis Care and Prevention

118Citations
N/AReaders
Get full text

What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats

92Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Richter, L. M., Lönnroth, K., Desmond, C., Jackson, R., Jaramillo, E., & Weil, D. (2014). Economic support to patients in HIV and TB grants in Rounds 7 and 10 from the Global Fund to Fight AIDS, Tuberculosis and Malaria. PLoS ONE, 9(1). https://doi.org/10.1371/journal.pone.0086225

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 78

72%

Researcher 18

17%

Lecturer / Post doc 8

7%

Professor / Associate Prof. 4

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 41

51%

Nursing and Health Professions 16

20%

Social Sciences 16

20%

Agricultural and Biological Sciences 8

10%

Save time finding and organizing research with Mendeley

Sign up for free